Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$119,765,926
+$117,309,557 QoQ
Shares Held
2,357,597
+2730.4% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.36049036370508.ToString("F0")%
None 2.6395096362949224.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. MRNA ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in MRNA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $119,765,926 | 2,357,597 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,456,369 | 83,295 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,235,509 | 86,547 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,070,629 | 38,805 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $82,088,981 | 2,895,555 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $162,789,523 | 3,915,092 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $349,165,696 | 5,224,685 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $512,830,305 | 4,318,571 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $597,237,148 | 5,604,703 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $718,583,828 | 7,225,579 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $579,572,479 | 5,611,119 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $623,892,536 | 5,134,918 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $659,201,449 | 4,292,235 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $768,228,270 | 4,276,964 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $557,087,691 | 4,711,101 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $624,447,202 | 4,371,349 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $52,284,523 | 303,521 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $106,389,677 | 418,890 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,592,850 | 43,114 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $35,342,868 | 150,408 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,791,591 | 21,318 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,314,126 | 12,579 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,987,366 | 28,090 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||